Amplia Therapeutics Limited (ASX:ATX)

Amplia Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	21	15	16	28	28	4
Market Cap Growth	179.79%	-9.41%	-41.33%	0.13%	628.25%	-32.88%
Enterprise Value	16	12	7	25	24	3
Last Close Price	0.05	0.07	0.08	0.14	0.25	0.05
PS Ratio	6.14	3.36	13.86	14.17	18.31	112.63
PB Ratio	1.64	1.31	1.04	1.29	2.72	0.45
P/TBV Ratio	4.33	4.29	2.09	2.02	11.69	5.77
EV/Sales Ratio	4.82	2.59	5.99	12.57	15.85	77.35
Debt / Equity Ratio	0.00	0.14	0.14	0.10	-	-
Asset Turnover	0.22	0.27	0.06	0.11	0.15	0.00
Quick Ratio	4.21	1.93	3.78	31.03	5.28	2.24
Current Ratio	4.35	1.98	3.82	31.18	5.45	2.31
Return on Equity (ROE)	-44.96%	-33.05%	-33.13%	-22.64%	-24.08%	-25.70%
Return on Assets (ROA)	-24.61%	-17.04%	-18.20%	-12.88%	-14.63%	-15.18%
Return on Capital (ROIC)	-26.21%	-18.36%	-18.68%	-13.28%	-15.44%	-16.09%
Earnings Yield	-29.54%	-30.15%	-37.85%	-12.96%	-8.13%	-57.58%
FCF Yield	-13.17%	-34.34%	-32.18%	-15.71%	-10.41%	-54.16%
Buyback Yield / Dilution	-15.38%	-0.02%	-33.27%	-53.71%	-95.36%	-21.92%

Updated Nov 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.